Otros idiomas Nobel Biocare Holding AG

Acciones

NOBN

CH0037851646

Diferido Swiss Exchange Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^CHF	-.--%		+0,29 %	-.--%

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Elos Medtech publ : signs global distribution agreement with Nobel Biocare	19/12/19
Nobel Biocare : Innovation comes to life at Nobel Biocare Global Symposium 2016	23/06/16
Nobel Biocare : enhances edentulous solutions offering with Locator R-Tx™ Attachment System	01/06/16
Nobel Biocare : announces NobelDesign – intuitive CAD software for dental restorations	23/02/16
Nobel Biocare : Hans Geiselhöringer appointed President of Nobel Biocare	18/01/16
Nobel Biocare : wins ruling; ITC issues Initial Determination that Instradent is guilty of patent infringement	02/11/15
Cancellation of publicly held Nobel Biocare shares and de-listing from SIX Swiss Exchange as of June 10, 2015	02/06/15
Befreiung von Vorschriften zur Aufrechterhaltung der Kotierung	23/01/15
Danaher controls more than 98% of Nobel Biocare and started squeeze out procedure; Nobel Biocare applied for delisting	19/01/15
Nobel Biocare appoints new Chief Financial Officer	07/01/15
Die ausserordentliche Generalversammlung der Nobel Biocare folgt allen Anträgen des Verwaltungsrats	15/12/14
The Extraordinary General Meeting of Nobel Biocare approves all proposals of the Board of Directors	15/12/14
Invitation to the Extraordinary Shareholders' Meeting	21/11/14
Einladung zur ausserordentlichen Generalversammlung	21/11/14
Nominations for the election to the Board of Directors	20/11/14
Nominationen für die Wahl in den Verwaltungsrat	20/11/14
Provisional notice of the interim result of the public tender offer of Danaher Corporation	17/11/14
Provisorische Meldung des Zwischenergebnisses des öffentlichen Kaufangebotes der Danaher Corporation	17/11/14
Innovation supports revenue growth acceleration in Q3; significantly improved underlying EBIT margin for the first nine months	06/11/14
Innovationen beschleunigen Wachstum im 3. Quartal. Deutlich verbesserte bereinigte EBIT-Marge für die ersten neun Monate.	06/11/14

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Nobel Biocare Holding AG

Acciones

NOBN

CH0037851646

Otros idiomas

Filtros